The ERCC1 C118T Polymorphism Predicts Clinical Outcomes of Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy: a Meta-analysis Based on 22 Studies
出版年份 2014 全文链接
标题
The ERCC1 C118T Polymorphism Predicts Clinical Outcomes of Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy: a Meta-analysis Based on 22 Studies
作者
关键词
-
出版物
Asian Pacific Journal of Cancer Prevention
Volume 15, Issue 19, Pages 8383-8390
出版商
Asian Pacific Organization for Cancer Prevention
发表日期
2014-12-19
DOI
10.7314/apjcp.2014.15.19.8383
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- GSTP1, ERCC1 and ERCC2 Polymorphisms, Expression and Clinical Outcome of Oxaliplatin-based Adjuvant Chemotherapy in Colorectal Cancer in Chinese Population
- (2013) Hui-Yan Li et al. Asian Pacific Journal of Cancer Prevention
- DNA Repair Gene Associated with Clinical Outcome of Epithelial Ovarian Cancer Treated with Platinum-based Chemotherapy
- (2013) Shan Kang et al. Asian Pacific Journal of Cancer Prevention
- Associations of ABCB1 and XPC Genetic Polymorphisms with Susceptibility to Colorectal Cancer and Therapeutic Prognosis in a Chinese Population
- (2013) Ai-Min Yue et al. Asian Pacific Journal of Cancer Prevention
- Effect of Variation of ABCB1 and ABCC3 Genotypes on the Survival of Bone Tumor Cases after Chemotherapy
- (2013) Jie Yang et al. Asian Pacific Journal of Cancer Prevention
- Single Nucleotide Polymorphisms in the NER Pathway and Clinical Outcome of Patients with Bone Malignant Tumor
- (2013) Xiao-Hui Sun et al. Asian Pacific Journal of Cancer Prevention
- Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer
- (2013) Kyung-Hun Lee et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer
- (2013) Lucía Cortejoso et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Genetic polymorphisms associated with oxaliplatin-induced peripheral neurotoxicity in Japanese patients with colorectal cancer
- (2013) Tomoyo Oguri et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- A Phase II Clinical Study of mFOLFOX6 Plus Bevacizumab as First-line Therapy for Japanese Advanced/Recurrent Colorectal Cancer Patients
- (2013) T. Nishina et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Predictive Role of ERCC1 and XPD Genetic Polymorphisms in Survival of Chinese Non-small Cell Lung Cancer Patients Receiving Chemotherapy
- (2012) Zhen-Yong Zhang et al. Asian Pacific Journal of Cancer Prevention
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pharmacogenetics of Oxaliplatin as Adjuvant Treatment in Colon Carcinoma
- (2012) Arantza Fariña Sarasqueta et al. Molecular Diagnosis & Therapy
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- ERCC1 and ERCC2 Polymorphisms Predict Clinical Outcomes of Oxaliplatin-Based Chemotherapies in Gastric and Colorectal Cancer: A Systemic Review and Meta-analysis
- (2011) Ming Yin et al. CLINICAL CANCER RESEARCH
- Associations between oxaliplatin-induced peripheral neuropathy and polymorphisms of the ERCC1 and GSTP1 genes
- (2011) M. Inada et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer
- (2011) Jian Cheng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Use of a comprehensive panel of biomarkers to predict response to a fluorouracil–oxaliplatin regimen in patients with metastatic colorectal cancer
- (2011) Maria J Lamas et al. PHARMACOGENOMICS
- Platinum-DNA Interactions and Subsequent Cellular Processes Controlling Sensitivity to Anticancer Platinum Complexes
- (2010) Saeed Ahmad CHEMISTRY & BIODIVERSITY
- Pharmacogenetic Assessment of Toxicity and Outcome in Patients With Metastatic Colorectal Cancer Treated With LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05
- (2010) Valérie Boige et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy
- (2010) Ming-Yii Huang et al. Pharmacogenetics and Genomics
- EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer
- (2009) K.-L. G. Spindler et al. ANNALS OF ONCOLOGY
- Molecular markers of response and toxicity to FOLFOX chemotherapy in metastatic colorectal cancer
- (2009) W Chua et al. BRITISH JOURNAL OF CANCER
- The combination of ERCC1 and XRCC1 gene polymorphisms better predicts clinical outcome to oxaliplatin-based chemotherapy in metastatic colorectal cancer
- (2009) Jun Liang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Influence ofGSTP1I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma
- (2009) Yen-Chung Chen et al. CANCER SCIENCE
- Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy
- (2008) L Paré et al. BRITISH JOURNAL OF CANCER
- ERCC1codon 118 C→T polymorphism associated withERCC1expression and outcome of FOLFOX-4 treatment in Asian patients with metastatic colorectal carcinoma
- (2008) Peter Mu-Hsin Chang et al. CANCER SCIENCE
- A distinct ERCC1 haplotype is associated with mRNA expression levels in prostate cancer patients
- (2008) A. Woelfelschneider et al. CARCINOGENESIS
- Platinum Resistance: The Role of DNA Repair Pathways
- (2008) L. P. Martin et al. CLINICAL CANCER RESEARCH
- Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer
- (2008) Eva Martinez-Balibrea et al. EUROPEAN JOURNAL OF CANCER
- Phase II Study of Weekly Intravenous Oxaliplatin Combined With Oral Daily Capecitabine and Radiotherapy With Biologic Correlates in Neoadjuvant Treatment of Rectal Adenocarcinoma
- (2008) Marwan G. Fakih et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
- (2008) Jim Cassidy et al. JOURNAL OF CLINICAL ONCOLOGY
- Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial
- (2008) Michael S. Braun et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started